Source link : https://newshealth.biz/health-news/grand-slam-in-pancreatic-cancer-novel-pill-doubles-survival/
CHICAGO — RASolute 302 trial results were hailed as a game-changing breakthrough in the treatment of pancreatic cancer. The phase III study showed that second-line daraxonrasib, an investigational oral RAS(ON) multi-selective inhibitor, doubled overall survival (OS) and progression-free survival (PFS) in patients with previously treated metastatic pancreatic ductal adenocarcinoma. In the primary endpoint population of […]
The post ‘Grand Slam’ in Pancreatic Cancer: Novel Pill Doubles Survival first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-31 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8